Request Legal Help Now - Free
LAWSUITS NEWS & LEGAL INFORMATION

Search Results for 

Sort by date 2,254 pages found matching General Motors

  • OxyContin officials spared jail
    Jul-21-07 Abington, VA As a drug, OxyContin has been getting a bad rap. Recently in the news for allegations of misbranding and suspect marketing practices by its manufacturer and abuse by addicts and youths, the OxyContin debacle appears to be a case of a worthy product taken advantage of by greedy profiteers and a lax regulatory framework. It is telling that,...
  • California Overtime Abuse Rampant in Retail
    Jul-21-07 Paris, CA Time and again there's another company not paying time-and-a half for overtime hours worked. Nancy Munoz worked almost a year in retail until she couldn't take any more 60-hour work weeks. "I started with this retail company last October," says Munoz. "I was hired as a senior assistant manager and it was to be a salaried position, 40-42 hour...
  • New Report on Avandia Risks
    Jul-16-07 Boston, MA The July issue of The New England Journal of Medicine reports an association between Avandia and heart failure, with more than twice as many heart failure cases in patients taking Avandia versus other diabetes drugs. An editorial published with the study advises doctors to consider the findings as they make prescription recommendations...
  • Zyprexa: Can you trust Eli Lilly?
    Jul-13-07 Washington, DC: The news has been full of stories about the anti-psychotic drug Zyprexa —Eli Lilly Co.'s big money-maker with the deadly side effects—and all the related litigation. Eli Lilly has been sued by individuals and sued by way of class action for failure to warn adequately that the drug can cause weight gain, diabetes, hypogly...
  • Medtronic Reducing Staff, Preparing for Defibrillator Lawsuits
    Jul-13-07 Fridley, MN Quality control seems to have gone the way of the dinosaur, while the word 'recall' has become part of our everyday vocabulary. How did we get here? And whatever happened to reliability? Especially when it comes to medical products? Take for example, Medtronic Implantable Cardioverter Defibrillators . In yet another example of implantable d...
  • Kugel Mesh Risk Widespread: Part 1
    Jul-11-07 Washington, DC: I learned some interesting things researching the lawsuits that have arisen because of defective Bard Composix Kugel Mesh patches. For one thing, did you know that hernia repairs are the most frequently performed general surgery in the world? There are about 20 million hernia repairs conducted annually worldwide. In the U.S., there...
  • Big Pharma Implant For-Profit Industry Not Deserving of Preemption Protection Part I
    Jul-9-07 Washington, DC: In addition to the question of how many soldiers will be dead or injured by the time self-proclaimed "war President" George Bush leaves office, Americans need to ask themselves how many citizens will be dead or injured as a result of an FDA controlled by the industry most credited with funding his move to the White House. Last year, the...
  • PPH: What were YOU doing in 1997?
    Jul-5-07 Madison, NJ Ten years is a long time to wait for the other shoe to drop. But that's the gist facing Americans who, prior to the FDA recall in 1997, had taken Fen-Phen, Redux or Pondimin for weight loss. Now, ten years on, the legal community is waiting for those shoes to drop, as there can be a ten-year delay between drug cessation, and the onset of Pr...
  • Seroquel: A $10 Billion Corporate Hit
    Jul-3-07 Wilmington, DE There you are, settling down for a relaxing few hours in front of the television after a hard day. Suddenly, a drug commercial (this time it's Seroquel ) comes on. The drug itself is of little consequence. The ads are all similar. Happy people depicted as living full and vibrant lives are set as the backdrop against a narrator heralding...
  • Problems Associated with Ketek Extend Beyond Liver Problems
    Jul-2-07 Washington, DC: The side effect most people think of when they hear the name Ketek is liver failure. However, at least one person has had a different, life-threatening reaction to Ketek; now patients are investigating the possibility of filing lawsuits against the manufacturer Sanofi-Aventis for serious side effects like toxic epidermal necrolysis (TEN)...
  • Complete MoisturePlus: Profits Fall for AMO Since Recall
    Jun-27-07 Santa Ana, CA It has been a little over a month since the AMO Complete MoisturePlus lens solution recall -- and beyond the damage done to people's eyes, is the fallout on the balance sheet. It is being reported that Advanced Medical Optics will lose anywhere from U.S. $57 million to $69 million this year alone, based on the anticipated lost sales of $...
  • Survey Indicates Blasé Attitude Toward Job-Terminating Disabilities
    Jun-17-07 Portland, ME Here are two bits of bad news: the number of disabled workers in the U.S. is on the rise, even as many Americans remain clueless about the financial impact of being struck down with a disability. Meanwhile, insurance giants such as the Unum Group continue to rake in huge bucks. Unum (formerly UnumProvident, prior to a March 2007 name-chan...
  • Glaxo now faces Lawsuit by Shareholders over Avandia Problems
    Jun-16-07 New York, NY GlaxoSmithKline PLC, the maker of the popular diabetes drug Avandia, just can't stay out of the news. And the news is all bad. Since May 21, when a meta-analysis (that is, an analysis of pooled data) of 42 clinical trials involving nearly 28,000 diabetes patients was published, showing that those taking Avandia had a 43% higher risk of...
  • Environmental Law: Whistle-blowers Have the Wind at Their Back
    Jun-11-07 Topeka, KA Sarah and Ray Dean are proof positive that you can take the environment into your own hands, and make a difference for the benefit of all. The Lawrence, Kansas couple has filed an environmental lawsuit demanding that the state limit carbon dioxide emissions. In doing so, the two environmentalists are testing the strength and tenacity of env...
  • The "Dark Side" of Fortune 1000 Companies' 401(k) Fees
    Jun-11-07 New York, NY An investigative report by Kiplinger's magazine has shed light on "the dark side of 401(k) fees" by some Fortune 1000 companies. Kiplinger's has identified "questionable business practices and conflicts of interest" associated with certain policies and fees. As well, experts have suggested that fees are being in essence "hidden" within...
  • Taking Zoloft During Pregnancy Linked to Birth Defects
    Jun-7-07 Washington, DC: Less than a year ago, in July 2006, the FDA issued a Public Health Advisory on a birth defect found to be associated with Zoloft and other selective serotonin reuptake inhibitor antidepressants by a study in the February 2006 New England Journal of Medicine that found a higher risk of a life-threatening lung disorder in infants exposed to...
  • Avandia and FDA now subject of Congressional Hearing
    Jun-6-07 Washington, DC Diabetes drug Avandia is making the news again this week, on two fronts. On June 6, 2007 a Congressional committee will hold a meeting to address the safety of Avandia, and the question of whether federal drug regulators (read the FDA) have paid close enough attention to its potential risks. The hearing before the House Committee on Ove...
  • Beazer Accused of Falsifying Loan Applications and Customer Satisfaction Surveys
    May-31-07 Charlotte, NC Beazer Homes Corp. and Beazer Mortgage Corp. face a lawsuit alleging the company violated the North Carolina General Statutes Chapter 75, which is designed to protect consumers by banning unfair business practices. The lawsuit, which seeks class action status, claims that Beazer illegally financed unqualified purchasers to buy newly built...
  • Overtime Back Pay Cases Sweep the U.S.
    May-31-07 Los Angeles, CA The LA Times reported May 30, 2007 that a handful of workers -- deported following an immigration sweep across California and 16 other states earlier this year -- are back in the country illegally and, in an interesting twist, are now claiming back wages in unpaid overtime they say their former employer owes them. A New York state co...
  • Feds Investigate Profits From Off-Label Stent Procedures - Part II
    May-25-07 Washington, DC: In addition to the federal investigations into the off-label marketing of drug eluting stents by Boston Scientific and Johnson & Johnson, on May 10, 2007, Rep Maurice Hinchey (D-NY), who serves on the House Appropriations Subcommittee, announced the introduction of the FDA reform bill which addresses the issue of doctors using product...
Page: 1  -  «100  -  «10  -  105  106  107  108  109  110  111  -  113   Next»



Request Legal Help Now! - Free